Benefits and Risks of Simvastatin in Patients with Familial Hypercholesterolaemia

Author： Mata P.  

Publisher： Adis International

ISSN： 0114-5916

Source： Drug Safety, Vol.26, Iss.11, 2003-01, pp. : 769-786

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Benefits and risks assessment of simvastatin in familial hypercholesterolaemia

By Alonso Rodrigo   Mata Nelva   Mata Pedro  

Expert Opinion on Drug Safety, Vol. 4, Iss. 2, 2005-03 ,pp. : 171-181

Informa Healthcare

Access to resources Recommend Favorite

Rationale, Design and Baseline Characteristics of a Clinical Trial Comparing the Effects of Robust vs Conventional Cholesterol Lowering and Intima Media Thickness in Patients with Familial Hypercholesterolaemia: The Atorvastatin versus Simvastatin on Atherosclerosis Progression (ASAP) Study

By Smilde T.J.  

Clinical Drug Investigation, Vol. 20, Iss. 2, 2000-08 ,pp. : 67-79

Adis International

Access to resources Recommend Favorite

Efficacy, Safety and Tolerability of Simvastatin in Children with Familial Hypercholesterolaemia: Rationale, Design and Baseline Characteristics

By Dejongh S.  

Clinical Drug Investigation, Vol. 22, Iss. 8, 2002-08 ,pp. : 533-540

Adis International

Access to resources Recommend Favorite

Ezetimibe/simvastatin provides VYTAL benefits in diabetic patients

By  

Inpharma, Vol. 1, Iss. 1571, 2007-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite

Pravastatin for children with familial hypercholesterolaemia

By  

Inpharma, Vol. 1, Iss. 1448, 2004-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite